Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

Clinical and Experimental Rheumatology

Volumn 27, Issue 2, 2009, Pages 267-271

  Sanchez, E ^a,l   Callejas Rubio, J L ^b   Sabio, J M ^c   Gonzalez Gay, M A ^d   Jimenez Alonso, J ^c   Mico L ^e   Ramón, E De ^f   Camps, M ^f   Suarez, A ^g   Gutierrez, C ^g   Garcia Portales, R ^h   Tolosa, C ⁱ   Ortego Centeno, N ^b   Sanchez Roman J ^j   Garcia Hernandez F J ^j   Gonzalez Escribano M F ^k   Martin, I ^a   Lopez Nevot M A ^c  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b Hospital Cilnico San Cecilio   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^d HOSPITAL XERAL CALDE   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^g DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

ⁱ Hospital Parc Taulf   (Spain)

^j Servicio de Medicina Interna   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l CSIC   (Spain)

more..

Author keywords

Polymorphisms; Susceptibility; Systemic lupus erythematosus; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7;

ALLELE; CAUCASIAN; CLINICAL EVALUATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; SPAIN; SYSTEMIC LUPUS ERYTHEMATOSUS;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTOR 7;

EID: 67249107279     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. RAHMAN A, ISENBERG DA: Systemic lupus erythematosus. N Engt J Med 2008; 358: 929-39.
2. SHMERLING RH: Autoantibodies in systemic lupus erythematosus--there before you know it. N Engt J Med 2003; 349: 1499-500.
3. ROELOFS MF, ABDOLLAHI-ROODSAZ S. JOOSTEN LA, VAN DEN BERG WB, RADSTAKE TR: The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 2008; 58: 338-48.
4. AKIRA 5, TAKEDA K, KAISHO T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675-80.
5. TAKEDA K, KAISHO T, AKIRA S: Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
6. ADEREM A, ULEVITCH RJ: Toll-like receptors in the induction of the innate immune response. Nature 2000; 406: 782-7.
7. IWASAKI A, MEDZHITOV R: Toll-like receptor control of the adaptive immune responses. Nat Inimunot 2004; 5: 987-95.
8. HAYASHI F, SMITH KD, OZINSKY A et at.: The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-103.
9. MOSER KL, NEAS BR, SALMON JE et at.: Genome scan of human systemic lupus crythematosus: evidence for linkage on chromosome lq in African-American pedigrees. Proc Natl Acad Sci USA 1998; 95: 14869-74.
10. TSAO BP, CANTOR RM, GROSSMAN JM et at.: PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest 1999; 103: 1135 -40.
11. HAWN TR, VERBON A, LETFINGA KD et at.: A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease. J Exp Med 2003; 198: 1563-72.
12. GEWIRTZ AT, VIJAY-KUMAR M, BRANT SR. DUERR RH, NICOLAE DL, CHO JH: Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn 's disease. Am J Physiol Gastrointest Liver Physiot 2006; 290: G1157-63.
13. HAWN TR, WU H, GROSSMAN JM, HAHN RH, TSAO BP, ADEREM A: A stop codon polymorphism of Toll-like receptor 5 is associated with resistance to systemic lupus crythematosus. Proc Natl Acad Sci USA 2005; 102: 10593-7.
14. BARRAT FJ. MEEKER T, GREGORIO J et at.: Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005; 202: 1131-9.
15. DIEBOLD SS, KAISHO T, HEMMI H. AKIRA S, REIS E SOUSA C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-31.
16. PISITKUN P, DEANE JA, DIFILIPPANTONIO MJ, TARASENKO T, SATFERTHWAITE AR, BOLLAND S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312: 1669-72.
17. SUBRAMANIAN S, TUS K, LI QZ et at.: A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Nail Acad Sci USA 2006; 103: 9970-5.
18. PASCUAL V. FARKAS L, BANCHEREAU J: Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunot 2006; 18: 676-82.
19. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
20. SANCHEZ E, GOMEZ LM, LOPEZ-NEVOT MA et al.: Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus. Genes Immun 2006; 7: 433-6.
21. DEMIRCI FY, MANZI S. RAMSEY-GOLDMAN R et at.: Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 2007; 34:1708-11.
22. SCHOTT E, WITT H, NEUMANN K et at.: A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 2007; 47: 203-11.
23. PIERIK M, JOOSSENS S. VAN STEEN K et al.: Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowet Dis 2006; 12: 1-8.
24. BROWNING BL, HUEBNER C, PETERMANN I et at.: Has toll-like receptor 4 been prematurely dismissed as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterot 2007; 102: 2504-12.
25. COOK DN, PISETSKY DS, SCHWARTZ DA: Toll-like receptors in the pathogenesis of human disease. Nat Immunot 2004; 5: 975-9.
26. SCHWARTZ DA, COOK DN: Polymorphisms of the Toll-like receptors and human disease. Ctin Infect Dis 2005; 41 (Suppl. 7): S403-7.
27. COOKE A, FERRACCIOLI GF, HERRMANN M et at.: Induction and protection of auto- immune rheumatic diseases. The role of infections. Clin Exp Rheumatol 2008; 26: S 1-7.
28. KELLEY J, JOHNSON MR. ALARCON GS, KIMBERLY RP. EDBERG JC: Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum 2007; 56: 3375-8.
29. WHITACRE CC: Sex differences in auto- immune disease. Nat Immunol 2001; 2: 777-80.
30. KIROU KA, LEE C, GEORGE S et at.: Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 395 8-67.
31. MARSHAK-ROTHSTEIN A: Tolling for autoimmunity-prime time for 7. Immunity 2006; 25: 397-9.
32. KAWAI T, ADACHI O, OGAWA T, TAKEDA K. AKIRA 5: Unresponsiveness of MyD88-defi- cient mice to endotoxin. Immunity 1999; 11: 115-22.
33. SCHNARE M, BARTON GM, HOLT AC, TAKEDA K, AKIRA 5, MEDZHITOV R: Toil-like receptors control activation of adaptive immune responses. Nat Immunot 2001; 2: 947-50.
34. SANCHEZ E, OROZCO G, LOPEZ-NEVOT MA, JIMENEZ-ALONSO J, MARTIN J: Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004; 63: 54-7.
35. SANCHEZ E, MORALES 5, PACO L et at.: Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (1L23A) gene polymorphism in systemic lupus erythematosus. Rheumatotogy (Oxford) 2005; 44: 1136-9.
36. SANCHEZ E, RUEDA B, CALLEJAS JL et at.: Analysis of interleukin-23 receptor (1L23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens 2007; 70: 233-7.
37. SANCHEZ E, SABIO JM, CALLEJAS JL et al.: Association study of genetic variants of pro- inflammatory chemokine and cytokine genes in systemic lupus erythematosus. BMC Med Genet 2006; 7: 48.
38. LAFYATIS R, MARSHAK-ROTHSTEIN A: Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res Ther 2007; 9: 222.